Lexaria Bioscience’s Financial Moves Spark Debate Amid Innovative Tech Developments
Lexaria Bioscience Corp’s innovative technology has sparked excitement in the pharmaceutical industry, but its recent financial decisions, including a $2 million direct offering, have raised concerns and led to a decline in investor confidence.
2 minutes to read